Tzung-Jie Yang

Title: Tzung-Jie Yang: Innovator in Neurotensin Receptor Research

Introduction

Tzung-Jie Yang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on the neurotensin receptor 1 (NTSR1), which plays a crucial role in various physiological processes.

Latest Patents

Tzung-Jie Yang holds a patent for "Humanized anti-human neurotensin receptor 1 antibodies and their uses." This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases and disorders related to NTSR1 activity and signaling. Additionally, the patent includes a method or kit for detecting NTSR1 in a sample. He has 1 patent to his name.

Career Highlights

Throughout his career, Tzung-Jie Yang has worked with notable institutions such as the Development Center for Biotechnology and the National Health Research Institutes. His research has contributed to advancements in understanding and targeting NTSR1, which has implications for various medical conditions.

Collaborations

Tzung-Jie Yang has collaborated with esteemed colleagues, including Cheng-Chou Yu and Shu-Ping Yeh. Their joint efforts have furthered research in the field and enhanced the potential applications of their findings.

Conclusion

Tzung-Jie Yang is a key figure in the realm of neurotensin receptor research, with a focus on developing innovative therapeutic solutions. His contributions continue to impact the field of biotechnology and medicine.